Sec. 5.
(a)
Furosemide may be administered intravenously to a horse that is entered to
compete in a race under the following conditions:
(1) The horse's licensed trainer, or a
licensed veterinarian, determines that it would be in the horse's best
interests to race with furosemide.
(2) Notice that a horse eligible to race on
furosemide will race, with or without furosemide, shall be made at the time of
entry to ensure public notification, including publication in the official
racing program.
(3) If a horse's
licensed trainer, or a licensed veterinarian, determines that it is no longer
in the horse's best interests to race with furosemide, the horse shall not be
eligible to receive furosemide unless the licensed trainer, or a licensed
veterinarian, later determines that it would be in the horse's best interests
to resume furosemide treatments for racing, and the licensed trainer or
licensed veterinarian complies with the requirements of this section.
(4) Furosemide shall only be administered on
association grounds.
(5) Upon the
request of the commission or its designee, the veterinarian administering
furosemide shall surrender the syringe used to administer such medication,
which may then be submitted for testing.
(6) A horse eligible to receive furosemide
must be treated at least four (4) hours, and not more than four (4) hours and
twenty-five (25) minutes, prior to the scheduled post time of its
race.
(7) Furosemide shall be
administered by a veterinarian licensed by the commission at an intravenous
dose level not to exceed five hundred (500) milligrams and not less than one
hundred fifty (150) milligrams. Administration of furosemide shall take place
in the test barn or a specific location otherwise designated by the commission.
An association employee shall be present and observe the drawing of furosemide
into a syringe. The administering veterinarian shall provide a factory sealed
bottle of furosemide from which the draws shall be made. The association shall
establish track rules for furosemide administrations that are consistent with
these regulations.
(8) The test
level of furosemide under this rule shall not be in excess of one hundred (100)
nanograms per milliliter of serum or plasma and shall not be below a urine
specific gravity of one and ten one-thousandths (1.010). If an insufficient
volume of urine is obtained, a positive test shall be based upon quantitative
testing performed on blood serum or plasma only. Split sample testing shall be
quantitative and be performed on blood serum or plasma only.
(b) It shall constitute a
violation of these rules if notice is made pursuant to this section that a
horse will race with furosemide, and a post-race sample of urine, serum, or
plasma obtained from that horse does not contain furosemide at a level
detectable by the official commission laboratory.
IC
4-22-2-37.1 establishes the
effectiveness of an emergency rule upon filing with the secretary of state. LSA
Document #99-107(E) was filed with the secretary of state June 8, 1999.
